Tsumura & Co. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 4,272 full-time employees. The firm operates the Pharmaceuticals segment. In Japan, the Company conducts the manufacturing, sales, transportation and storage of prescription drugs and over-the-counter drugs, and cultivation, procurement, selection, processing and storage of raw medicinal herbs. In China, the Company is engaged in regional management, business management, production and sales of herbal extract powders, cultivation, procurement, selection, processing and storage of herbal ingredients, and sales of pharmaceuticals and food products. In Laos, the Company is engaged in cultivation, procurement, selection, processing and storage of herbal ingredients. In the United States, the Company is engaged in pharmaceutical development business.
Follow-Up Questions
Tsumura & Co의 CEO는 누구입니까?
Mr. Terukazu Kato은 2011부터 회사에 합류한 Tsumura & Co의 President입니다.
TSMRF 주식의 가격 성능은 어떻습니까?
TSMRF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Tsumura & Co의 주요 사업 주제나 업종은 무엇입니까?
Tsumura & Co은 Pharmaceuticals 업종에 속하며, 해당 부문은 Health Care입니다
Tsumura & Co의 시가총액은 얼마입니까?
Tsumura & Co의 현재 시가총액은 $0입니다
Tsumura & Co는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 3명의 분석가가 Tsumura & Co에 대한 분석 평가를 실시했으며, 이는 1명의 강력한 매수, 4명의 매수, 5명의 보유, 0명의 매도, 그리고 1명의 강력한 매도를 포함합니다
